Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Talking Rheumatology Research - Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

01/11/24 • 18 min

Talking Rheumatology Research

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.

Listen now to hear the findings and what this means for future clinical practice!

You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology.

The countdown to #BSR25 begins!
Our full Annual Conference 2025 programme is now available. Browse 100+ sessions and get ready for an inspiring event.
https://bit.ly/4bGFX1N

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

plus icon
bookmark

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.

Listen now to hear the findings and what this means for future clinical practice!

You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology.

The countdown to #BSR25 begins!
Our full Annual Conference 2025 programme is now available. Browse 100+ sessions and get ready for an inspiring event.
https://bit.ly/4bGFX1N

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Previous Episode

undefined - Ep 41. Addressing the leaky pipeline

Ep 41. Addressing the leaky pipeline

What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology.
Want to read more? Here's your further reading list:
1. Read Christina and Isabella's full paper
2. Read Latika's work on the gender gap in journal Editorial Boards

The countdown to #BSR25 begins!
Our full Annual Conference 2025 programme is now available. Browse 100+ sessions and get ready for an inspiring event.
https://bit.ly/4bGFX1N

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Next Episode

undefined - Ep. 43 The metaverse: a new frontier for rheumatology

Ep. 43 The metaverse: a new frontier for rheumatology

Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients.

Listen now to hear about the current technological developments and what this means for future clinical practice!

You can read this article [https://doi.org/10.1093/rheumatology/kead534] in Rheumatology.

The countdown to #BSR25 begins!
Our full Annual Conference 2025 programme is now available. Browse 100+ sessions and get ready for an inspiring event.
https://bit.ly/4bGFX1N

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/talking-rheumatology-research-280592/ep-42-combination-therapy-or-autologous-hematopoietic-stem-cell-transp-41727342"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to ep 42. combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis? on goodpods" style="width: 225px" /> </a>

Copy